William Ciambrone
2020
Compensation breakdown
| Non-Equity Incentive Plan | $207,259 |
|---|---|
| Salary | $458,179 |
| Other | $14,500 |
| Total | $679,938 |
Ciambrone received $458.2K in salary, accounting for 67% of the total pay in 2020.
Ciambrone also received $207.3K in non-equity incentive plan and $14.5K in other compensation.
Rankings
In 2020, William Ciambrone's compensation ranked 10,071st out of 13,090 executives tracked by ExecPay. In other words, Ciambrone earned more than 23.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,071 out of 13,090 | 23rd |
Division Manufacturing | 4,322 out of 5,617 | 23rd |
Major group Chemicals And Allied Products | 1,780 out of 2,248 | 21st |
Industry group Drugs | 1,557 out of 1,948 | 20th |
Industry Pharmaceutical Preparations | 1,147 out of 1,453 | 21st |
Pay ratio
| William Ciambrone's Pay | $679,938 |
|---|---|
| Median Employee's Pay | $275,247 |
| Pay Ratio | 2to 1 |
In 2020, the annual total compensation of William Ciambrone was $679,938.
The annual total compensation of the median employee at Sarepta Therapeutics was $275,247.
The ratio of William Ciambrone's pay to the pay of median employee was therefore 2 to one.
Ciambrone's colleagues
We found seven more compensation records of executives who worked with William Ciambrone at Sarepta Therapeutics in 2020.
2020
Louise Rodino-Klapac
Sarepta Therapeutics
Chief Scientific Officer
2020
David Howton
Sarepta Therapeutics
General Counsel
2020
Ian Estepan
Sarepta Therapeutics
Chief Financial Officer
2020
Gilmore MMSc
Sarepta Therapeutics
Chief Scientific Officer
2020
Sandesh Mahatme
Sarepta Therapeutics
Chief Financial Officer
2020
Douglas Ingram
Sarepta Therapeutics
Chief Executive Officer
2020
Joseph Bratica
Sarepta Therapeutics